JPH02169507A - Cosmetic - Google Patents
CosmeticInfo
- Publication number
- JPH02169507A JPH02169507A JP63321940A JP32194088A JPH02169507A JP H02169507 A JPH02169507 A JP H02169507A JP 63321940 A JP63321940 A JP 63321940A JP 32194088 A JP32194088 A JP 32194088A JP H02169507 A JPH02169507 A JP H02169507A
- Authority
- JP
- Japan
- Prior art keywords
- saponin
- formula
- extract
- examples
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 33
- 229930182490 saponin Natural products 0.000 claims abstract description 40
- 150000007949 saponins Chemical class 0.000 claims abstract description 40
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims abstract description 33
- 239000000126 substance Substances 0.000 claims abstract description 16
- 150000001875 compounds Chemical class 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000000419 plant extract Substances 0.000 claims description 5
- 150000003904 phospholipids Chemical class 0.000 abstract description 18
- 239000000284 extract Substances 0.000 abstract description 15
- 241000196324 Embryophyta Species 0.000 abstract description 7
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract description 3
- 241000580938 Sapindus Species 0.000 abstract description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 244000269722 Thea sinensis Species 0.000 abstract 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 1
- 235000017709 saponins Nutrition 0.000 description 35
- 239000006210 lotion Substances 0.000 description 15
- 239000000243 solution Substances 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 9
- 239000003205 fragrance Substances 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- 239000002884 skin cream Substances 0.000 description 7
- 239000008777 Glycerylphosphorylcholine Substances 0.000 description 6
- 229960004956 glycerylphosphorylcholine Drugs 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 235000013336 milk Nutrition 0.000 description 6
- 210000004080 milk Anatomy 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- 244000068988 Glycine max Species 0.000 description 5
- 235000010469 Glycine max Nutrition 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 206010040880 Skin irritation Diseases 0.000 description 3
- 239000006096 absorbing agent Substances 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- -1 polyoxyethylene chain Polymers 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- 241000258957 Asteroidea Species 0.000 description 2
- 240000001548 Camellia japonica Species 0.000 description 2
- 244000301850 Cupressus sempervirens Species 0.000 description 2
- 240000004670 Glycyrrhiza echinata Species 0.000 description 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000219925 Oenothera Species 0.000 description 2
- 235000004496 Oenothera biennis Nutrition 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 241001122767 Theaceae Species 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 2
- 239000010775 animal oil Substances 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 235000018597 common camellia Nutrition 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 239000010696 ester oil Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 150000002402 hexoses Chemical class 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940010454 licorice Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 150000002972 pentoses Chemical class 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 235000008160 pyridoxine Nutrition 0.000 description 2
- 239000011677 pyridoxine Substances 0.000 description 2
- GUEIZVNYDFNHJU-UHFFFAOYSA-N quinizarin Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C(O)=CC=C2O GUEIZVNYDFNHJU-UHFFFAOYSA-N 0.000 description 2
- 229940048730 senega Drugs 0.000 description 2
- 238000005063 solubilization Methods 0.000 description 2
- 230000007928 solubilization Effects 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 150000003432 sterols Chemical group 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 235000015961 tonic Nutrition 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 238000002834 transmittance Methods 0.000 description 2
- 150000003648 triterpenes Chemical group 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 1
- CSTRPYAGFNTOEQ-MGMRMFRLSA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;octadecanoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCCCC(O)=O CSTRPYAGFNTOEQ-MGMRMFRLSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- LPLVUJXQOOQHMX-IOHDZAKGSA-N (2s,3s,4s,5r,6r)-6-[(2s,3r,4s,5s,6s)-2-[[(3s,4ar,6ar,6bs,8as,11s,12as,14ar,14bs)-11-carboxy-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1h-picen-3-yl]oxy]-6-carboxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-c Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-IOHDZAKGSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 2,3-dimethylbutane Chemical group CC(C)C(C)C ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 0.000 description 1
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- 244000307700 Fragaria vesca Species 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 244000130592 Hibiscus syriacus Species 0.000 description 1
- 235000018081 Hibiscus syriacus Nutrition 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 244000230712 Narcissus tazetta Species 0.000 description 1
- 241000238413 Octopus Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 102000015439 Phospholipases Human genes 0.000 description 1
- 108010064785 Phospholipases Proteins 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Natural products OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000019169 all-trans-retinol Nutrition 0.000 description 1
- 239000011717 all-trans-retinol Substances 0.000 description 1
- ZOJBYZNEUISWFT-UHFFFAOYSA-N allyl isothiocyanate Chemical compound C=CCN=C=S ZOJBYZNEUISWFT-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 125000003289 ascorbyl group Chemical group [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229940071162 caseinate Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000003026 cod liver oil Substances 0.000 description 1
- 235000012716 cod liver oil Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- RGLYKWWBQGJZGM-ISLYRVAYSA-N diethylstilbestrol Chemical compound C=1C=C(O)C=CC=1C(/CC)=C(\CC)C1=CC=C(O)C=C1 RGLYKWWBQGJZGM-ISLYRVAYSA-N 0.000 description 1
- 229960000452 diethylstilbestrol Drugs 0.000 description 1
- 229940031569 diisopropyl sebacate Drugs 0.000 description 1
- WQLVFSAGQJTQCK-UHFFFAOYSA-N diosgenin Natural products CC1C(C2(CCC3C4(C)CCC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 WQLVFSAGQJTQCK-UHFFFAOYSA-N 0.000 description 1
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 229960003399 estrone Drugs 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- 235000012701 green S Nutrition 0.000 description 1
- 239000004120 green S Substances 0.000 description 1
- WDPIZEKLJKBSOZ-UHFFFAOYSA-M green s Chemical compound [Na+].C1=CC(N(C)C)=CC=C1C(C=1C2=CC=C(C=C2C=C(C=1O)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=CC(=[N+](C)C)C=C1 WDPIZEKLJKBSOZ-UHFFFAOYSA-M 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- PABHEXWDYRTPBQ-UHFFFAOYSA-N methyl 3-[2,5-di(propan-2-yl)phenyl]prop-2-enoate Chemical compound COC(=O)C=CC1=CC(C(C)C)=CC=C1C(C)C PABHEXWDYRTPBQ-UHFFFAOYSA-N 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000008164 mustard oil Substances 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- NWMIYTWHUDFRPL-UHFFFAOYSA-N sapogenin Natural products COC(=O)C1(CO)C(O)CCC2(C)C1CCC3(C)C2CC=C4C5C(C)(O)C(C)CCC5(CCC34C)C(=O)O NWMIYTWHUDFRPL-UHFFFAOYSA-N 0.000 description 1
- 239000003998 snake venom Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は、化粧料に関し、特にモノアシル型リン脂質お
よびサポニンを組合せて含む化粧料に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to cosmetics, and particularly to cosmetics containing a combination of monoacyl phospholipids and saponins.
[従来の技術および発明が解決しようとする課題]近年
、乳化および可溶化に関する研究が数多くなされlこ。[Prior art and problems to be solved by the invention] In recent years, many studies have been conducted on emulsification and solubilization.
その結果、乳化剤および可溶化剤ならびに乳化技術およ
び可溶化技術が進歩し、非常に安定な乳化物および可溶
化物が多くの分野で利用されている。As a result, advances in emulsifiers and solubilizers and emulsification and solubilization techniques have resulted in highly stable emulsions and solubilizates being utilized in many fields.
その乳化剤および可溶化剤の多くは、ポリオキシエチレ
ン鎖を有する非イオン型界面活性剤、脂肪酸石けんで代
表されるアニオン型界面活性剤、カチオン型界面活性剤
および両性型界面活性剤である。しかし、これらの合成
界面活性剤を使用した乳化化粧料、可溶化(透明)化粧
料は、一般に皮膚や毛髪に刺激を与えやすい難点がある
。Most of the emulsifiers and solubilizers are nonionic surfactants having a polyoxyethylene chain, anionic surfactants typified by fatty acid soaps, cationic surfactants, and amphoteric surfactants. However, emulsified cosmetics and solubilized (transparent) cosmetics using these synthetic surfactants generally have the disadvantage that they tend to irritate the skin and hair.
このような背景のもと、リン脂質、特にモノアシル型リ
ン脂質が注目されるようになった。特開昭61−112
007号公報には、モノアシル型リン脂質を可溶化剤と
して使用した透明化粧料が、特開昭61−171407
@公報には、モノアシル型リン脂質を乳化剤として使用
した乳化型化粧料が開示されている。Against this background, phospholipids, particularly monoacyl phospholipids, have attracted attention. Japanese Patent Publication No. 61-112
No. 007 discloses a transparent cosmetic using monoacyl phospholipids as a solubilizing agent, disclosed in Japanese Patent Application Laid-open No. 171407/1983.
The publication @ discloses an emulsified cosmetic using a monoacyl phospholipid as an emulsifier.
しかしながら、モノアシル型リン脂質を用いて調製した
従来の透明化粧料および乳化化粧料は、保存安定性、特
に低温および高温環境下での保存安定性に問題があった
。また、官能特性(特に滑らかさの持続)、および外観
(肌目、透明性)などの面で、より一層の改良の必要性
があった。However, conventional transparent cosmetics and emulsified cosmetics prepared using monoacyl phospholipids have problems with storage stability, especially storage stability under low and high temperature environments. Further, there was a need for further improvement in terms of organoleptic properties (particularly lasting smoothness) and appearance (texture, transparency).
すなわち、透明化粧料を低温条件(5℃以下)あるいは
高温条件(、40′C以上)で保存すると、モノアシル
型リン脂質の沈殿が生じ、またはにごりやずいという問
題があった。一方、乳化化粧料を低温条件または高温条
件で保存すると、粘度および肌目等の外観が変化してし
まう欠点があった。That is, when transparent cosmetics are stored under low temperature conditions (below 5° C.) or high temperature conditions (above 40'C), there is a problem in that monoacyl phospholipids precipitate or they become cloudy or sour. On the other hand, when emulsified cosmetics are stored under low or high temperature conditions, they have the disadvantage that their viscosity and appearance, such as texture, change.
一方、サポニンはステロール或はトリテルペンなどの無
極性グループ(サポグニン)と、1(ペントース、ヘキ
ソース、ウロン酸など)が結合した化合物である。その
存在は、ある種のヒトデを例外として広く植物界に見ら
れる。一種の植物中に、多種類のサポニンが存在するこ
とが多い。サポニンは、近年、医薬成分として研究され
ているが、化粧料への利用の例は少い。甘草成分として
のサポニン(グリチルリチン類)を抗炎症作用、抗アレ
ルギー作用、抗原抗体抑制作用、ステロイドホルモン作
用などの観点で化粧品に利用することが示唆されている
(フレグランスジャーナル。On the other hand, saponin is a compound in which a nonpolar group (sapogni) such as a sterol or triterpene is bound to 1 (pentose, hexose, uronic acid, etc.). Its presence is widespread throughout the plant kingdom, with the exception of certain starfish. Many types of saponins are often present in a single plant. Saponin has been studied as a medicinal ingredient in recent years, but there are few examples of its use in cosmetics. It has been suggested that saponin (glycyrrhizin), a licorice ingredient, may be used in cosmetics for its anti-inflammatory, anti-allergic, antigen-antibody suppressing, and steroid hormone effects (Fragrance Journal).
Vol 3 、 No、 4. 39−41.1975
) 、月見草の種子からの油を含む皮膚化粧料において
、油の酸敗または酸化を防止する安定剤として、ミシマ
サイコの根またはチュの根茎の抽出物を配合することが
知られており、該抽出物はサポニンを含有する(特開昭
61−178908号公報)。ムクロジの果皮の水仙出
液を主成分とする洗髪料が知られており、洗髪用として
実用しうる起泡力および洗浄力を示すとされる(特開昭
52−125510号公報)。タコなどのマシ油、ポリ
オキシエチレンソルビタンセスキオレエート、又はポリ
オキシエチレンソルビタンモノステアレートが用いられ
ている(特公昭58−40923号公報)。Vol 3, No. 4. 39-41.1975
), it is known that in skin cosmetics containing oil from evening primrose seeds, an extract of the root of the evening primrose or the rhizome of the chinensis is blended as a stabilizer to prevent rancidity or oxidation of the oil. contains saponin (JP-A-61-178908). A hair wash containing daffodil extract from the peel of Sapindica as a main ingredient is known, and is said to exhibit foaming power and detergency that can be used practically for hair washing (Japanese Patent Application Laid-open No. 125510/1983). Mustard oil such as octopus oil, polyoxyethylene sorbitan sesquioleate, or polyoxyethylene sorbitan monostearate is used (Japanese Patent Publication No. 40923/1983).
[課題を解決するための手段]
本発明者等は前記モノアシル型リン脂質を用いる化粧料
の欠点を解決するために鋭意研究した結果、後記一般式
(1)または(2)で表わされるモノアシル型リン脂質
とサポニンとを組合せて使用すると、保存中に於る沈殿
乃至濁りの発生が無く、また官能特性および外観が良く
なることを見い出した。[Means for Solving the Problem] As a result of intensive research in order to solve the drawbacks of cosmetics using the monoacyl type phospholipid, the present inventors found that the monoacyl type phospholipid represented by the general formula (1) or (2) below It has been found that when phospholipids and saponins are used in combination, no precipitation or turbidity occurs during storage, and the organoleptic properties and appearance are improved.
このような組合せの効果は、従来の技術がら予8111
されない。The effect of such a combination is as expected from the conventional technology.
Not done.
すなわち本発明は、油性物質および水を含有する化粧料
において、
下記の一般式(1)
%式%
または下記の一般式(2)
(上記の式中で、Rは−C−C17H35゜で表わされ
る化合物の少なくとも一つと、サポニンまたはサポニン
を含有する植物抽出物より選ばれた少なくとも一種とを
含有することを特徴とする化粧料である。That is, the present invention provides a cosmetic composition containing an oily substance and water, which has the following general formula (1) % formula % or the following general formula (2) (in the above formula, R is represented by -C-C17H35°). This cosmetic is characterized by containing at least one compound selected from saponin or a plant extract containing saponin.
本発明における前記一般式(1)および(2)で表わさ
れる化合物、すなわちモノー〇−アシルー3−グリセリ
ルホスホリルコリン、モノー〇−アシルー3−グリセリ
ルホスホリルエタノールアミン、モノー〇−アシルー3
−グリセリルホスホリルイノシトール自体は、公知であ
る。一般式(1)で表わされる化合物としては、1−バ
ルミトイル−3−グリセリルホスホリルコリン、1−ス
テアロイル−3−グリセリルホスホリルコリン、1−バ
ルミトイル−3−グリセリルホスホリルエタノールアミ
ン、1−ステアロイル−3−グリセリルホスホリルエタ
ノールアミン、1−バルミトイル−3−グリセリルホス
ホリルイノシトール、1−ステアロイル−3−グリセリ
ルホスホリルイノシトールが挙げられる。一般式(2)
で表わされる化合物としては、2−バルミトイル−3−
グリセリルホスホリルコリン、2−ステアロイル−3−
グリセリルホスホリルコリン、2−バルミトイル−3−
グリセリルホスホリルエタノールアミン、2−ステアロ
イル−3−グリセリルホスホリルエタノールアミン、2
−バルミトイル−3−グリセリルホスホリルイノシトー
ル、2−ステアロイル−3−グリセリルホスホリルイノ
シトールが挙げられる。Compounds represented by the above general formulas (1) and (2) in the present invention, i.e., mono-acyl-3-glycerylphosphorylcholine, mono-acyl-3-glycerylphosphorylethanolamine, mono-acyl-3
- Glycerylphosphorylinositol itself is known. Examples of the compound represented by the general formula (1) include 1-valmitoyl-3-glycerylphosphorylcholine, 1-stearoyl-3-glycerylphosphorylcholine, 1-valmitoyl-3-glycerylphosphorylethanolamine, and 1-stearoyl-3-glycerylphosphorylethanol. Examples include amine, 1-valmitoyl-3-glycerylphosphorylinositol, and 1-stearoyl-3-glycerylphosphorylinositol. General formula (2)
As a compound represented by 2-valmitoyl-3-
Glycerylphosphorylcholine, 2-stearoyl-3-
Glycerylphosphorylcholine, 2-valmitoyl-3-
Glycerylphosphorylethanolamine, 2-stearoyl-3-glycerylphosphorylethanolamine, 2
-Valmitoyl-3-glycerylphosphorylinositol and 2-stearoyl-3-glycerylphosphorylinositol.
前記の一般式(1)および(2)で表わされる化合物は
例えば、卵黄より得られるホスファチジルコリン、ホス
ファチジルエタノールアミンまたはホスファチジルイノ
シトールを原料として、蛇毒ホスホリパーゼまたは豚す
い臓抽出酵素のパンクレアチンで処理し、高速液体クロ
マトグラフィーにより分画して得られる。あるいは化学
的に合成することによっても得られる。The compounds represented by the above general formulas (1) and (2) are produced, for example, by treating phosphatidylcholine, phosphatidylethanolamine or phosphatidylinositol obtained from egg yolk with snake venom phospholipase or pancreatin, an enzyme extracted from porcine pancreas, into a high-speed liquid. Obtained by fractionation by chromatography. Alternatively, it can be obtained by chemical synthesis.
前記の一般式(1)および(2)で表わされる化合物は
人体に安全であり、その皮膚刺激については、Drai
zcの方法に準じてテストした結果、動物皮膚刺激スコ
アー、人体皮膚刺激スコアーは何れも0(ゼロ)であり
、無刺激性であることを確認している。 (Dralz
e、 J、 H,、As5ociation of F
oodand Drug officials of
the United 5tates。The compounds represented by the above general formulas (1) and (2) are safe for the human body, and their skin irritation has been reported by Drai.
As a result of testing according to the ZC method, the animal skin irritation score and human skin irritation score were both 0 (zero), confirming that it is non-irritating. (Dralz
e, J, H,,As5ociation of F
oodand drug official of
The United 5tates.
Appraisal of the 5afet
y of Chea+1cals 1nFood
s、 Drugs and Cosmetfcs 、
4B (1959)。Appraisal of the 5afet
y of Chea+1cals 1nFood
s, Drugs and Cosmetfcs,
4B (1959).
Texas、 5tate Departraent
of Health、 Au5tin、)本発明におけ
る前記の一般式(1)および(2)で表わされる化合物
は、乳化剤および可溶化剤として一種または二種以上を
組合せて使用される。Texas, 5tate Department
of Health, Au5tin,) The compounds represented by the above general formulas (1) and (2) in the present invention are used singly or in combination as emulsifiers and solubilizers.
本発明に用いるサポニンおよびサポニンを含有する植物
抽出物は公知である。Saponins and saponin-containing plant extracts used in the present invention are known.
本発明におけるサポニンは、前記したようにステロール
或いはトリテルペンという無極性グループ(サポゲニン
)と糖(ペントース、ヘキソース、ウロン酸等)が結合
した化合物であると定義される。As described above, saponin in the present invention is defined as a compound in which a nonpolar group such as a sterol or triterpene (sapogenin) is bound to a sugar (pentose, hexose, uronic acid, etc.).
その存在は、ある種のヒトデを例外として一般に広(植
物界に見られ、かつ一種の植物中に多種類のサポニンが
存在する。本発明ではその出所および取得法は特に限定
されるものではないが、例えば、ファルマシアVo1.
15. No、10897〜899(1979)に記載
される麦門冬、天門冬、商陸、セネガ、遠志、人参、特
開昭56−160981号公報に記載されている大豆、
特開昭56−127316号公報に記載されているアマ
チャズル、フレグランスジャーナルVo1.3. Na
439〜41 (1975)に記載されている甘草、特
開昭61−178908号公報に記載されている、ヒマ
ワリ(Ilctianthus annuus L、)
の種子、ミシマサイコ(Buplcurui+ fal
catun L、)の根、チュ(Sanguisorb
a officinalis L、)の根茎、特開昭5
2−125510号公報に記載されているムクロジの果
皮、特公昭42−10923号公報記載されているミシ
マサイコの根等、特公昭5g−40923号公報に記載
されている薊、クコ、シコン、側芯、水蛭、特開昭57
−106807号公報に記載されているセネガ、ハマメ
リス、オオヘビイチゴ、アルテアなどがサポニンを含む
ソースとして挙げられる。本発明では、上記した各種植
物を、公知法で抽出して得たサポニンを合釘する植物抽
出物またはこれを精製して得たサポニンを用いることが
できる。Its existence is generally widespread, with the exception of certain types of starfish (it is found in the plant kingdom, and many types of saponins exist in one type of plant. In the present invention, the source and method of obtaining it are not particularly limited. For example, Pharmacia Vol.
15. No. 10897-899 (1979) Mugimon Fuyu, Tenmon Fuyu, Sho Riku, Senega, Toshi, Ginseng, soybean described in JP-A-56-160981,
Amachazul Fragrance Journal Vol. 1.3, which is described in Japanese Patent Application Laid-open No. 56-127316. Na
439-41 (1975), and sunflower (Ilctianthus annuus L,) described in JP-A-61-178908.
Seeds of Buplcurui + fal
catun L,) root, Chu (Sanguisorb)
Rhizome of a officinalis L.), JP-A-1978
The pericarp of Sapindium japonica described in Japanese Patent Publication No. 2-125510, the roots of Japanese cypress described in Japanese Patent Publication No. 42-10923, the iris, wolfberry, cypress, and lateral core described in Japanese Patent Publication No. 5g-40923. , Mizuhiru, JP-A-57
Examples of sources containing saponin include Senega, Hamamelis, Strawberry and Althea, which are described in Japanese Patent Publication No. 106807. In the present invention, a plant extract obtained by extracting saponin from the various plants described above by a known method, or a saponin obtained by purifying the same can be used.
特に、け草から得られるサポニン(α−またはβ−グリ
チルリチンまたはその誘導体)、ムクロジ果皮抽出物、
大豆サポニン、チュの根茎抽出物、茶の種子抽出物、椿
の種子抽出物が好ましいものの例として挙げられる。In particular, saponin (α- or β-glycyrrhizin or its derivatives) obtained from Kegusa, Sapindica pericarp extract,
Preferred examples include soybean saponin, Chu rhizome extract, tea seed extract, and camellia seed extract.
上記した式(1)および(2)で表わされる化合物の配
合量、および前記サポニンまたはサポニンを含(:iす
る植物抽出物の配合量(サポニン含量として)は化粧料
の総量を基準として夫々大略0.01〜10重量%、好
ましくは0.1〜5重量%である。The amount of the compound represented by the above formulas (1) and (2) and the amount of the saponin or plant extract containing saponin (as saponin content) are approximately based on the total amount of the cosmetic. It is 0.01 to 10% by weight, preferably 0.1 to 5% by weight.
式(1)および(2)の化合物またはサポニンの一方で
も上記量より少いと、化粧料の保存安定性が劣る。また
、これらが、上記量より多いと、それ自身が系に完全に
溶解しきれずに分離する傾向があり、また化粧料の使用
時の感触が悪(なりやすい。If the amount of either the compound of formula (1) or (2) or saponin is less than the above amount, the storage stability of the cosmetic will be poor. In addition, if these amounts exceed the above-mentioned amount, they tend to separate without being completely dissolved in the system, and the cosmetic composition tends to have a poor feel when used.
本発明に使用する油性物質とは、広(油性物質を意味し
、たとえば油溶性香料、油溶性ビタミン類、油溶性ホル
モン類、油溶性色素類、油溶性紫外線吸収剤類、高級脂
肪族炭化水素類、植物性油脂、動物性油脂、ロウ類、高
級脂肪酸、高級アルコール、合成エステル油等を挙げる
ことができる。The oil-based substances used in the present invention refer to a wide range of oil-based substances, such as oil-soluble fragrances, oil-soluble vitamins, oil-soluble hormones, oil-soluble pigments, oil-soluble ultraviolet absorbers, and higher aliphatic hydrocarbons. Examples include oils, vegetable oils, animal oils, waxes, higher fatty acids, higher alcohols, synthetic ester oils, and the like.
さらに詳しく説明すると、油溶性香料としては例えば天
然動植物から抽出した油溶性香料や合成の油溶性香料が
挙げられる。油溶性ビタミン類としては例えば、ビタミ
ンA1ビタミンD1ビタミンE1 ビタミンF1ビタミ
ンに群のビタミン、シカプリル酸ピリドキシン、シバル
ミチン酸ピリドキシン、酢酸d1−α−トコフェロール
、ニコチン酸dΩ−α−トコフェロール、シバルミチン
酸アスコルビル、モノパルミチン酸アスコルビル、モノ
ステアリン酸アスコルビル等のビタミン誘導体が挙げら
れる。油溶性ホルモン類としては例えば、エストラジオ
ール、エチニルエストラジオール、エストロン、ジエチ
ルスチルベストロール等、油溶性色素類としては例えば
、スダン■、テトラブロムフルオレセイン、ジブロムフ
ルオレセイン、フルオレセイン、キニザリングリーンS
S等、油溶性紫外線吸収剤類としては例えば、オキシベ
ンゾン、2.5−ジイソプロピル桂皮酸メチル等が挙げ
られる。More specifically, examples of oil-soluble fragrances include oil-soluble fragrances extracted from natural animals and plants and synthetic oil-soluble fragrances. Examples of oil-soluble vitamins include vitamin A1 vitamin D1 vitamin E1 vitamin F1 vitamin group vitamins, pyridoxine caprilate, pyridoxine cybalmitate, d1-α-tocopherol acetate, dΩ-α-tocopherol nicotinate, ascorbyl cybalmitate, Examples include vitamin derivatives such as ascorbyl palmitate and ascorbyl monostearate. Examples of oil-soluble hormones include estradiol, ethinylestradiol, estrone, and diethylstilbestrol; examples of oil-soluble pigments include Sudan ■, tetrabrome fluorescein, dibrome fluorescein, fluorescein, and quinizarin green S.
Examples of oil-soluble ultraviolet absorbers such as S include oxybenzone, methyl 2,5-diisopropyl cinnamate, and the like.
高級脂肪族炭化水素類としては例えば、流動パラフィン
、スクワラン、マイクロクリスタリンワックス、ワセリ
ン、セレシン等、植物性油脂としては例えばオリーブ油
、ヒマシ油、カカオ脂、パーム油等、動物性油脂として
は例えばタラ肝油、牛脂、バター脂等、ロウ類としては
、例えば蜜ロウ、カルナウバロウ等、高級脂肪酸として
は、例えばラウリン酸、ミリスチン酸、パルミチン酸、
ステアリン酸、オレイン酸、ベヘニン酸、ラノリン脂肪
酸等、高級アルコールとしては、FfIえばラウリルア
ルコール、ステアリルアルコール、セチルアルコール、
オレイルアルコール等、合成エステル油としては、例え
ばブチルステアレート、ヘキシルラウレート、オクチル
ドデシルミリステート、ジイソプロピルアジベート、ジ
イソプロピルセバケート等の直鎖エステル、分岐鎖エス
テル等を挙げることができる。Examples of higher aliphatic hydrocarbons include liquid paraffin, squalane, microcrystalline wax, petrolatum, and ceresin; examples of vegetable oils include olive oil, castor oil, cacao butter, and palm oil; and examples of animal oils include cod liver oil. Waxes such as , beef tallow and butter fat include beeswax and carnauba wax, and higher fatty acids include lauric acid, myristic acid, palmitic acid,
Examples of higher alcohols include stearic acid, oleic acid, behenic acid, lanolin fatty acids, etc.FfI include lauryl alcohol, stearyl alcohol, cetyl alcohol,
Examples of synthetic ester oils such as oleyl alcohol include straight chain esters and branched chain esters such as butyl stearate, hexyl laurate, octyl dodecyl myristate, diisopropyl adibate, and diisopropyl sebacate.
これらの油性物質は、一種または二種以上組合わせて使
用される。These oily substances may be used singly or in combination.
ローションやヘアートニック等の透明化粧料の場合、こ
れら油性物質の配合量は、処方成分の全量重量を基準と
して大略0.0001〜1重量%、好ましくは、0.0
01〜0.3重量%である。大略o、oooi重量%よ
°り少ないと当該油性物質の固有の特性効果が少なくな
り、大略1重量%より多くなるとその可溶化が困難とな
り易い傾向がある。In the case of transparent cosmetics such as lotions and hair tonics, the blending amount of these oily substances is approximately 0.0001 to 1% by weight, preferably 0.0001 to 1% by weight based on the total weight of the prescription ingredients.
01 to 0.3% by weight. If it is less than about o or oooi weight %, the characteristic effects inherent to the oily substance will be reduced, and if it is more than about 1 weight %, it tends to be difficult to solubilize it.
また、クリームや乳液等の乳化化粧料の場合、油性物質
の配合量は、当該乳化組成物における処方成分の全量重
量を基準として大略5〜80重量%、好ましくは10〜
60ffl量%である。大略5重量%より少ないと保存
安定性がやや悪くなると共に、乳化化粧料としては仕上
りがさっばりしすぎるし、大略80重量%より多いと油
のべたつきが著しくなり好ましくない。In the case of emulsified cosmetics such as creams and milky lotions, the amount of oily substances blended is approximately 5 to 80% by weight, preferably 10 to 80% by weight, based on the total weight of the prescription ingredients in the emulsified composition.
The amount is 60ffl%. If it is less than about 5% by weight, the storage stability will be somewhat poor and the finish will be too light for an emulsified cosmetic, and if it is more than about 80% by weight, the oil will become extremely sticky, which is undesirable.
本発明の化粧料には、必要に応じて保湿剤、美容薬効成
分、芳香剤、防腐剤、着色剤、紫外線吸収剤、収れん剤
、合成界面活性剤、顔料(カオリン、マイカ、セリサイ
ト、タルク、黄酸化鉄、赤酸化鉄等)、水溶性天然高分
子(カゼインソーダ、ペクチン、キサンタンガム、カラ
ヤガム、ローカストビーンガム、カラギーナン等)を添
加することができる。The cosmetics of the present invention may contain moisturizing agents, cosmetic medicinal ingredients, fragrances, preservatives, coloring agents, ultraviolet absorbers, astringents, synthetic surfactants, pigments (kaolin, mica, sericite, talc, etc.) as necessary. , yellow iron oxide, red iron oxide, etc.), water-soluble natural polymers (caseinate soda, pectin, xanthan gum, karaya gum, locust bean gum, carrageenan, etc.) can be added.
本発明の化粧料としては、例えば、整肌化粧水、拭き取
り化粧水、柔軟化粧水、アクネトリートメントローショ
ン、アフターシェーブローション、二層型コンディショ
ニングローション、クレンジングローション、ヘアート
ニック、マツサージクリーム、クレンジングクリーム、
スキンクリーム、スキンミルク、ファンデーションクリ
ーム、メイクアップベース、ヘアークリーム等が挙げら
れるが、これらに限定されない。The cosmetics of the present invention include, for example, a skin conditioning lotion, a wiping lotion, a softening lotion, an acne treatment lotion, an aftershave lotion, a two-layer conditioning lotion, a cleansing lotion, a hair tonic, a pine surge cream, a cleansing cream,
Examples include, but are not limited to, skin cream, skin milk, foundation cream, makeup base, hair cream, and the like.
[実 施 例] 以下、実施例について説明する。[Example] Examples will be described below.
実施例に示す「部」は重量部を意味する。"Parts" shown in Examples mean parts by weight.
実施例において調べた化粧料の特性は、保存安定性、官
能特性、pit、透過度および外観である。The properties of the cosmetics investigated in the examples were storage stability, sensory properties, pit, permeability, and appearance.
その試験方法は次の通りである。The test method is as follows.
(1)保存安定性は、試料組成物を45℃、40℃、3
0℃、5°C1または0℃の恒温槽に3ケ月、4ケ月ま
たは6ケ月間放置し、その粘度または沈澱物の有無を検
査した。(1) Storage stability of sample composition at 45°C, 40°C, 3
The samples were left in a constant temperature bath at 0°C, 5°C, or 0°C for 3, 4, or 6 months, and their viscosity and the presence of precipitates were examined.
(2)官能特性は、塗布時の感触(さっばり感、しっと
り感、べたつき感、滑らかさ)、塗布後の仕上りを、専
門検査員3人によって調べ、総合評価した。(2) Sensory characteristics were comprehensively evaluated by examining the feel during application (lightness, moistness, stickiness, smoothness) and the finish after application by three specialized inspectors.
(3) pl!測定は化粧料の調製直後に行った。ガ
ラス電極を持つpH測定器をpH標準液で十分調整して
から、pl+を測定した。(3) pl! The measurements were taken immediately after the cosmetics were prepared. A pH meter with a glass electrode was sufficiently adjusted with a pH standard solution, and then pl+ was measured.
(4)透過度は、450nmの波長の光の光透過率を表
わす。その値が80%以」二であると、肉眼でも透明で
ある。(4) Transmittance represents the light transmittance of light with a wavelength of 450 nm. When the value is 80% or more, it is transparent even to the naked eye.
(5)外観は、肉眼にて着色状態等を判定した。(5) Regarding the appearance, the state of coloring etc. was determined with the naked eye.
実施例1〜5、比較例1〜2
第1表記載の処方(重量部)で、化粧水を調製した。リ
ン脂質として1−バルミトイル−3−グリセリルホスホ
リルコリンを用いた。また、用いた甘草サポニンは市販
入手したものであり、α−グリチルリチンを主として含
む。Examples 1 to 5, Comparative Examples 1 to 2 Lotions were prepared using the formulations (parts by weight) listed in Table 1. 1-valmitoyl-3-glycerylphosphorylcholine was used as the phospholipid. The licorice saponin used was commercially available and mainly contains α-glycyrrhizin.
表中成分1〜3を混合溶解しく溶液1)、別途に表中成
分4〜7を混合溶解した(溶液2)。溶液1に溶液2を
混合し、化粧水を調製した。得られた化粧水の特性を第
1表に併せて示す。Components 1 to 3 in the table were mixed and dissolved (solution 1), and components 4 to 7 in the table were separately mixed and dissolved (solution 2). Solution 2 was mixed with Solution 1 to prepare a lotion. The properties of the obtained lotion are also shown in Table 1.
表から判るように、本発明に従いリン脂質とサポニンの
両者を含む実施例の化粧水は、保存安定性に優れる。他
方、リン脂質またはサポニンの一方を欠く比較例1およ
び2の化粧水は保存安定性が悪く、沈澱、濁り、油滓が
生じる。本発明の化粧水は、官能特性および透明度にお
いても比較例より優れている。As can be seen from the table, the lotions of Examples containing both phospholipids and saponins according to the present invention have excellent storage stability. On the other hand, the lotions of Comparative Examples 1 and 2 that lack either phospholipid or saponin have poor storage stability, resulting in precipitation, turbidity, and soapstock. The lotion of the present invention is also superior to the comparative example in sensory properties and transparency.
実施例6〜lO1比較例3〜4
第2表に示す処方(重量部)で、スキンミルクを調製し
た。Examples 6 to 1O1 Comparative Examples 3 to 4 Skin milks were prepared according to the formulations (parts by weight) shown in Table 2.
リン脂質として、2−バルミトイル−3−グリセリルホ
スホリルエタノールアミンを用いた。サポニン含有抽出
物として、ムクロジ(Sapindusmukuros
il)果皮の含水エタノール抽出液を精製、乾燥して粉
末としたものを用いた。これは50乃至60%のサポニ
ンを含む。2-valmitoyl-3-glycerylphosphorylethanolamine was used as the phospholipid. As a saponin-containing extract, Sapindus mukuros
il) A water-containing ethanol extract of the pericarp was purified and dried to form a powder. It contains 50-60% saponin.
表中成分の油性成分1〜5を約80℃にて均一に混合溶
解した(溶液1)。表中成分の水溶性成分6〜10およ
び12を約80℃にて均一に溶解した(溶液2)。次に
溶液2をホモミキサーで攪拌しながら、溶液1を添加し
、乳化した後冷却した。尚、その冷却過程の70℃で成
分11を添加し、30℃まで降温後、攪拌を停止した。Oily components 1 to 5 listed in the table were uniformly mixed and dissolved at about 80°C (solution 1). Water-soluble components 6 to 10 and 12 listed in the table were uniformly dissolved at about 80°C (solution 2). Next, Solution 1 was added to Solution 2 while stirring with a homomixer, emulsified, and then cooled. Incidentally, component 11 was added at 70°C during the cooling process, and after the temperature was lowered to 30°C, stirring was stopped.
得られたスキンミルクの特性を第2表に示す。The properties of the obtained skin milk are shown in Table 2.
表から判るように、本発明に従いリン脂質とサポニンの
両者を含む実施例のスキンミルクは、保存安定性が良い
。しかし、リン脂質またはサポニンの一方を欠く比較例
3および4のスキンミルクは保存中に、著しく増粘また
は減粘し不安定である。本発明のスキンミルクは、官能
特性においても比較例より著しく優れており、外観も良
好である。As can be seen from the table, the skin milk of the Examples containing both phospholipids and saponins according to the present invention has good storage stability. However, the skin milks of Comparative Examples 3 and 4, which lack either phospholipid or saponin, significantly thicken or thin during storage and are unstable. The skin milk of the present invention is significantly superior to the comparative example in terms of organoleptic properties and also has a good appearance.
実施例11および比較例5(スキンクリーム)下記処方
(重量部)で、スキンクリームを調製した。リン脂質と
して、1−ステアロイル−3−グリセリルホスホリルイ
ノシトールを用い、サポニンとして大豆サポニン(サポ
ニン含量的80%)を用いた。Example 11 and Comparative Example 5 (Skin Cream) Skin creams were prepared using the following formulations (parts by weight). 1-stearoyl-3-glycerylphosphorylinositol was used as the phospholipid, and soybean saponin (80% saponin content) was used as the saponin.
オリーブ油
流動パラフィン
ミツロウ
セチルアルコール
グリセリルモノステア
白色ワセリン
実施例
5.0
15、(1
3,0
7,0
レート 3.0
3.0
1−ステアロイル−3=
グリセリルホスホリル
イノシトール
マルチトール液
バラオキシ安息香酸メ
大豆サポニン
香 料
精製水
チル
0.5
10.0
0.2
0.5
0.1
52.7
比較例
5.0
15.0
3.0
7.0
3.0
3.0
0.5
10.0
0.2
0.1
53.2
上記成分のうち油性成分1〜6を約80℃にて均一に混
合溶解した(溶液1)。上記成分のうち水溶性成分7〜
10および12を約80℃にて均一に混合溶解した(溶
液2)。次に溶液2をホモミキサーで攪拌しながら、溶
液1を添加し、乳化した後冷却した。尚、その冷却過程
の70℃で成分11を添加し、30°Cまで降温後、攪
拌を停止した。Olive Oil Liquid Paraffin Beeswax Cetyl Alcohol Glyceryl Monostear White Petrolatum Example 5.0 15, (1 3,0 7,0 Rate 3.0 3.0 1-stearoyl-3= Glycerylphosphorylinositol Maltitol Liquid Rose Oxybenzoic Acid Mesoybean Saponin fragrance purified water chill 0.5 10.0 0.2 0.5 0.1 52.7 Comparative example 5.0 15.0 3.0 7.0 3.0 3.0 0.5 10.0 0.2 0.1 53.2 Of the above components, oily components 1 to 6 were uniformly mixed and dissolved at about 80°C (solution 1).
10 and 12 were uniformly mixed and dissolved at about 80°C (solution 2). Next, Solution 1 was added to Solution 2 while stirring with a homomixer, emulsified, and then cooled. Incidentally, component 11 was added at 70°C during the cooling process, and after the temperature was lowered to 30°C, stirring was stopped.
かくして得られた実施例11のスキンクリームはO/
W型のエマルジョンであり、45℃の恒温槽内で4ケ月
間保存した時に安定性が極めて良好であった。また、0
℃および5℃で6ケ月保存後も極めて安定であった。変
質、変臭も起こらなかった。また肌目等の外観が良く、
感触、保湿性、使用性(とれ、延び等)が良かった。The skin cream of Example 11 thus obtained was O/
It was a W-type emulsion and had extremely good stability when stored in a constant temperature bath at 45°C for 4 months. Also, 0
It was extremely stable after storage for 6 months at 5°C and 5°C. No deterioration or odor occurred. In addition, the appearance of the skin is good,
The feel, moisturizing properties, and usability (removal, spreadability, etc.) were good.
大豆サポニンを使用せず、かつ水を53.2部使用する
他は、実施例11と同様に調製した比較例5のスキンク
リームは、0/w型のエマルジョンであり、45℃の恒
温槽内で4ケ月間保存したところ、クリーミングを起こ
し、保存安定性が悪かった。The skin cream of Comparative Example 5, which was prepared in the same manner as Example 11 except that soybean saponin was not used and 53.2 parts of water was used, was a 0/w type emulsion and was kept in a constant temperature bath at 45°C. When stored for 4 months, creaming occurred and storage stability was poor.
また、0℃で6ケ月間保存したところ、肌目が悪くなり
、塗布後の滑らかさが得られなかった。Furthermore, when stored at 0° C. for 6 months, the texture of the skin deteriorated and smoothness could not be obtained after application.
実施例11における大豆サポニンに代えて、甘草抽出物
(β−グリチルリチン)、ムクロジ果皮抽出物、茶の種
子抽出物、椿の種子抽出物またはチュの根茎抽出物を用
いて調製したスキンクリームも、実施例11のスキンク
リームとほぼ同じ挙動を示した。A skin cream prepared using licorice extract (β-glycyrrhizin), Sapindica pericarp extract, tea seed extract, camellia seed extract or Chu rhizome extract in place of the soybean saponin in Example 11, It exhibited almost the same behavior as the skin cream of Example 11.
[発明の効果]
本発明の化粧料は、高温および低温における保存安定性
に極めて優れ、また官能特性および外観も極めて良好で
ある。[Effects of the Invention] The cosmetic composition of the present invention has extremely excellent storage stability at high and low temperatures, and also has extremely good sensory characteristics and appearance.
Claims (1)
般式(1) ▲数式、化学式、表等があります▼・・・・・・・・・
(1) 又は下記の一般式(2) ▲数式、化学式、表等があります▼・・・・・・・・・
(2) (上記の式中で、Rは▲数式、化学式、表等があります
▼、 又は▲数式、化学式、表等があります▼ Xは▲数式、化学式、表等があります▼、 ▲数式、化学式、表等があります▼又は ▲数式、化学式、表等があります▼である) で表わされる化合物の少なくとも一つと、サポニンまた
はサポニンを含有する植物抽出物より選ばれた少なくと
も一種とを含有することを特徴とする化粧料。[Claims] In cosmetics containing oily substances and water, the following general formula (1) ▲There are mathematical formulas, chemical formulas, tables, etc.▼・・・・・・・・・
(1) Or the following general formula (2) ▲There are mathematical formulas, chemical formulas, tables, etc.▼・・・・・・・・・
(2) (In the above formula, R is ▲ has a mathematical formula, chemical formula, table, etc. ▼, or ▲ has a mathematical formula, chemical formula, table, etc. ▼ X is ▲ has a mathematical formula, chemical formula, table, etc. ▼, ▲ mathematical formula, Contains at least one compound represented by chemical formula, table, etc. ▼ or ▲ mathematical formula, chemical formula, table, etc. ▼) and at least one selected from saponin or a plant extract containing saponin. Cosmetics featuring:
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63321940A JP2652228B2 (en) | 1988-12-22 | 1988-12-22 | Cosmetics |
AT89203315T ATE119384T1 (en) | 1988-12-22 | 1989-12-22 | COSMETIC PREPARATION. |
ES89203315T ES2076203T3 (en) | 1988-12-22 | 1989-12-22 | COSMETIC COMPOSITION. |
EP89203315A EP0375082B1 (en) | 1988-12-22 | 1989-12-22 | Cosmetic composition |
DE68921584T DE68921584T2 (en) | 1988-12-22 | 1989-12-22 | Cosmetic preparation. |
US07/627,694 US5567419A (en) | 1988-12-22 | 1990-12-14 | Stabilized cosmetic compositions containing monoacyl phosphatide and a saponin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63321940A JP2652228B2 (en) | 1988-12-22 | 1988-12-22 | Cosmetics |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH02169507A true JPH02169507A (en) | 1990-06-29 |
JP2652228B2 JP2652228B2 (en) | 1997-09-10 |
Family
ID=18138119
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63321940A Expired - Lifetime JP2652228B2 (en) | 1988-12-22 | 1988-12-22 | Cosmetics |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2652228B2 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03197408A (en) * | 1989-12-27 | 1991-08-28 | Kobayashi Kose Co Ltd | Stabilization of liposome and phospholipid dispersion |
JPH05255102A (en) * | 1992-03-13 | 1993-10-05 | Shiseido Co Ltd | Testosterone-5-alpha-reductase inhibitor |
JP2004519411A (en) * | 2000-03-28 | 2004-07-02 | ビルケン ゲーエムベーハー | Emulsion containing plant extract, method for producing said emulsion and method for obtaining plant extract |
KR100821842B1 (en) * | 2006-11-30 | 2008-04-14 | 주식회사 엘지생활건강 | Anti-allergy skin care cosmetic composition |
CN112957291A (en) * | 2021-02-19 | 2021-06-15 | 杭州市红十字会医院 | Skin-whitening and anti-aging skin-care composition |
US11083733B2 (en) | 2018-01-04 | 2021-08-10 | Amryt Research Limited | Betulin-containing birch bark extracts and their formulation |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01176442A (en) * | 1987-12-28 | 1989-07-12 | Nonogawa Shoji:Kk | Oil-in-polyhydric alcohol type emulsified composition and oil-in-water type emulsified composition |
-
1988
- 1988-12-22 JP JP63321940A patent/JP2652228B2/en not_active Expired - Lifetime
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01176442A (en) * | 1987-12-28 | 1989-07-12 | Nonogawa Shoji:Kk | Oil-in-polyhydric alcohol type emulsified composition and oil-in-water type emulsified composition |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03197408A (en) * | 1989-12-27 | 1991-08-28 | Kobayashi Kose Co Ltd | Stabilization of liposome and phospholipid dispersion |
JPH05255102A (en) * | 1992-03-13 | 1993-10-05 | Shiseido Co Ltd | Testosterone-5-alpha-reductase inhibitor |
JP2004519411A (en) * | 2000-03-28 | 2004-07-02 | ビルケン ゲーエムベーハー | Emulsion containing plant extract, method for producing said emulsion and method for obtaining plant extract |
KR100821842B1 (en) * | 2006-11-30 | 2008-04-14 | 주식회사 엘지생활건강 | Anti-allergy skin care cosmetic composition |
US11083733B2 (en) | 2018-01-04 | 2021-08-10 | Amryt Research Limited | Betulin-containing birch bark extracts and their formulation |
US11266660B2 (en) | 2018-01-04 | 2022-03-08 | Amryt Research Limited | Betulin-containing birch bark extracts and their formulation |
US11826374B2 (en) | 2018-01-04 | 2023-11-28 | Amryt Research Limited | Betulin-containing birch bark extracts and their formulation |
CN112957291A (en) * | 2021-02-19 | 2021-06-15 | 杭州市红十字会医院 | Skin-whitening and anti-aging skin-care composition |
Also Published As
Publication number | Publication date |
---|---|
JP2652228B2 (en) | 1997-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH08245367A (en) | Lipid composition for fragrances and cosmetics and its preparation | |
JPH06336419A (en) | External agent for skin | |
EP0375082B1 (en) | Cosmetic composition | |
JPH08259433A (en) | Cosmetic or preparation for external use containing humectant composition | |
US5567419A (en) | Stabilized cosmetic compositions containing monoacyl phosphatide and a saponin | |
JPH08225428A (en) | Cosmetic | |
JP2652228B2 (en) | Cosmetics | |
JPH0532556A (en) | Skin agent for external use | |
JPS61130232A (en) | Shikonin-containing composition | |
JP2000247987A (en) | Highly hydrogenated lecithin | |
JPS61204109A (en) | Emulsion-type composition for external use | |
JP2000026228A (en) | Collagenase inhibitor, moisturizer, and cosmetic or food containing the same | |
JP3597520B2 (en) | External preparation for skin | |
JP5641665B2 (en) | External preparation for skin and method for producing the same | |
JP2004123661A (en) | Skin care preparation for external use | |
JP2781626B2 (en) | Solubilized transparent cosmetic | |
JP2004123657A (en) | External preparation for skin | |
JP4418550B2 (en) | Hydrophobic licorice extract-containing composition | |
WO2023234345A1 (en) | External skin preparation containing unsaponified concentrate of rice bran oil | |
JPH06690B2 (en) | Soluble water-based transparent cosmetic | |
KR102381622B1 (en) | Stabilizing method of rice bran wax and cosmetic composition containing the stabilized rice bran wax | |
JP2002179549A (en) | Skin care preparation | |
JPH0665047A (en) | External preparation for skin | |
JP2811479B2 (en) | Hair restoration | |
JPH0552288B2 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080523 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090523 Year of fee payment: 12 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090523 Year of fee payment: 12 |